The strategic acquisition will strengthen access to care, enhance outcomes and support local healthcare teamsOTTAWA, Ontario, May 14, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a trusted provider of mission-critical solutions for defence, space and healthcare announced today it has acquired Advanced Medical Solutions (AMS), a leading provider of remote and emergency healthcare services in Northern Canada. The acquisition is effective immediately. About AMS Headquartered in Yellowknife, Northwest ...

LONDON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings from How Smarter Home Delivery Wins Younger Consumers as Online Buying Slows, its fourth annual consumer sentiment study of ecommerce home delivery. The study shows that, in a slower growing ecommerce market, consumers aged 18-35 (“under 35s”) are the biggest contributor to online growth, increasing both the volume an ...

MANNHEIM, Germany, May 14, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) notifying the Company that, in accordance with Nasdaq Listing Rule 5101, 5110(b) and IM-5101-1, the trading of the Company’s common shares will be suspended at the opening of business on ...

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) is pleased to report its operational and financial results for the first quarter of 2025. All dollar amounts are in USD unless otherwise indicated and abbreviation “M” means million. First Quarter 2025 Highlights Gold production of 28,688 oz AISC per oz sold of $1,415 Revenue of $82.7M from the sale of 28,943 gold oz at an average realized price of $2,851 per oz Adjusted E ...

Strategic partnership with leading USV company enhances Red Cat’s multi-domain capabilities and capitalizes on rapidly growing global demand for autonomous, kinetic-capable platformsSAN JUAN, Puerto Rico, May 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat"), a leading provider of drone technology for military, government, and commercial operations, today announced the expansion of its multi-domain Family of Systems with a new line of Unmanned Surface Vessels (USVs). This strate ...

Core Insights - SFL Corporation Ltd. reported preliminary financial results for Q1 2025, including a net loss of $31.9 million or $0.24 per share, primarily due to impairments on older dry-bulk vessels and the idleness of the drilling rig Hercules [1][6] - The company declared a quarterly cash dividend of $0.27 per share, marking the 85th consecutive quarterly dividend [5][6] - Charter hire revenue for the quarter was $193.5 million, which included $1.5 million from profit share, while adjusted EBITDA was $108.0 million from consolidated subsidiaries and $7.7 million from associated companies [6] Financial Performance - The net loss of $31.9 million was attributed to one-off items, including impairments on older vessels [3][6] - Charter hire revenue was reported at $193.5 million, with an adjusted EBITDA of $115.7 million when including associated companies [6] - The company has been actively repurchasing shares, with a $10 million buyback at an average price of $7.98 per share [6] Fleet Management - SFL continues to renew its fleet by divesting older bulkers and containerships, focusing on assets with a charter backlog to support long-term dividend distribution [4][6] - The company upgraded several vessels during the quarter, enhancing cargo intake and fuel efficiency [3][4] Dividend Information - The declared quarterly cash dividend of $0.27 per share will be paid on or around June 27, 2025, with the record date set for June 12, 2025 [5][6] - This dividend reflects the company's commitment to maintaining a consistent distribution to shareholders [8]

Group 1 - WithSecure's Annual General Meeting authorized the Board of Directors to issue a maximum of 17,609,870 shares, valid until the next Annual General Meeting or no later than 30 June 2026 [1] - Up to 2,000,000 shares may be allocated for share-based incentive schemes [1] - The Board of Directors has resolved to issue a maximum of 180,445 treasury shares, which includes 128,221 shares for Board compensation and 52,224 shares for the Restricted Share Plan 2022-2024 [3] Group 2 - The issuance of shares deviates from shareholders' pre-emptive rights due to a significant financial reason related to Board remuneration and incentive schemes [3]

Core Insights - Metagenomi, Inc. has made significant advancements in gene editing technologies, particularly for treating neurological disorders through extrahepatic in vivo gene editing [1][2] - The company presented three abstracts at the ASGCT 28 Annual Meeting, showcasing its proprietary gene editing toolbox, including compact nucleases and CRISPR-associated transposases (CAST) [1][2] Gene Editing Technologies - The metagenomics discovery platform utilizes natural microbial evolution and AI-guided protein optimization to identify and enhance novel gene editing systems [2] - Compact Type II and Type V nucleases have been developed for efficient in vivo editing, with a focus on delivering large therapeutic genes [2][9] - The CAST system has shown promise in addressing challenges related to targeted and precise large gene integration [2] Presentation Highlights - A compact type II CRISPR system (MG21-1) demonstrated up to 69% target protein reduction in the CNS with localized AAV9 delivery [6] - An ultra-compact type V nuclease (MG119-28) achieved over 50% restoration of dystrophin protein levels in DMD model myocytes and 64% knockdown of target protein in the motor cortex [6] - The type V-K CAST system has improved integration efficiency by over 50 times compared to natural systems, indicating its potential for therapeutic applications [9] Company Overview - Metagenomi leverages AI and machine learning to develop next-generation genome editing therapeutics, analyzing over 7.4 billion proteins to target various genetic mutations [7] - The company has a lead program in Hemophilia A, aiming to provide lifelong protection from bleeding events and joint damage [7]

Core Insights - Titan Mining Corporation reported a 37% year-over-year revenue increase for Q1 2025, reaching $16.02 million, alongside a 4% reduction in all-in sustaining costs (AISC) [1][7] - The company achieved a payable zinc production of 15.37 million pounds, a 5% increase from Q1 2024, and a significant cash flow from operations of $2.69 million, up 922% year-over-year [7][8] - Exploration results indicate potential mineral resource expansion, with a notable intercept of 11.6 feet at 13.7% Zn, approximately 1,750 feet outside the current mineral resource model [4][11] Financial Performance - Revenue for Q1 2025 was $16.02 million, a 37% increase compared to $11.73 million in Q1 2024 [7] - Net income after tax was $0.35 million, compared to a loss of $2.63 million in Q1 2024 [7] - Cash flow from operating activities was $2.69 million, significantly up from $0.26 million in Q1 2024 [7] Operational Highlights - The average realized zinc price was $1.29 per pound, up from $1.11 per pound in Q1 2024 [7] - C1 cash costs decreased to $0.91 per pound, down 6% from $0.97 per pound in Q1 2024, while AISC was $0.96 per pound, down 4% from $1.00 per pound in Q1 2024 [7][8] - The company drilled 22 holes totaling 9,213 feet in underground exploration, focusing on the Mahler, New Fold, and Mud Pond zones [11] Strategic Developments - Titan is advancing its dual-commodity growth plan with robust cash flow from zinc operations and rapid progress on the Kilbourne graphite project [5][10] - The Kilbourne Graphite Project is on track to produce 1,000–1,200 tonnes of graphite concentrate per year, with plans to increase production to 40,000 tonnes per year, marking the first fully integrated natural flake graphite production in the U.S. since 1956 [10][28] - The company is implementing a production expansion from 1,750 to 2,250 tons/day, expected to be completed by year-end [9][28]

Earnings Call Scheduled for 8:30 a.m. U.S. Eastern Time on Wednesday, May 21, 2025HONG KONG, May 14, 2025 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before U.S. markets open on Wednesday, May 21, 2025. Management will hold a conference call to discuss these results at 8:30 a.m. U.S. ...